share price, page-2

I closed out my short. That tells you what I think. The short term risk is to the upside and as was pointed out to me by a relative who is in the pathology profession, the window is wide open for a company like ADO to penetrate the IVD market.
What convinced me to close was his comment that Mix&Go may be just the product a "Roche" or similar is looking for. That would have a very big impact on the price, hence the closing.
A Roche signing or similar would see the price spike strongly.
I don't think contracts with bead manufacturers is exciting but potentially the IVD market is.